Analyst Ratings for GlaxoSmithKline (GSK) [Neutrals]

GSK Rating Summary

GSK Price Target Summary

* Over Last 12-Mos
  |   Expand Research on GSK
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $55.50 (+14.2%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
7/28/2014 BofA/Merrill Lynch Downgrade Neutral
(Buy)
54.00
(63.00)
48.60 48.59 -0.02% Details
1/24/2014 Berenberg Downgrade Hold
(Buy)
N/A
(N/A)
54.90 48.59 -11.49% Details
Like GSK Ratings? Also take a look at THRX, RNA, LGND, PFE

GSK Ratings News